The rigorous science behind our services

Our team is dedicated to producing commercially relevant insights into healthcare cost and quality. No one brings greater insight and understanding to the challenge of empowering patients, improving healthcare, ensuring quality, and reducing medical costs. Below are examples of our research and white papers.

White Paper: Implementing SDM at the Point of Care

For more than two decades, shared decision making has been recognized for its potential to empower patients and reduce utilization for preference sensitive conditions. As the United States increasingly moves to a value-based healthcare system that places an emphasis on patient experience as well as the cost of care, SDM has become a hot topic.

This white paper provides background on shared decision making, describes how the market has changed (resulting in renewed interest), and offers a high-level roadmap with 5 tips for its successful adoption by provider groups and health plans.


White Paper: Improving Medication Adherence

Increasing medication adherence across a population is vital to improving your CMS Five-Star and HEDIS ratings, and to the success of chronic care management programs. Medication non-adherence causes poor clinical outcomes, which then increases the use of expensive and potentially avoidable healthcare services.

In this white paper, we discuss best practices for achieving medication compliance, as well as the case study results from one of our medication therapy management programs.


Infographic: Consumers Are Going Online for Help with Their Health

Traditional disease management programs are changing. Digital technology has created new opportunities for payers, providers, and employers to reach and engage healthcare consumers. Digital health engagement tools, such as health portals and apps, can deliver effective, personalized health education and resources that help users better manage chronic conditions, prevent avoidable disease, and stay well.

Download this infographic to learn 5 key factors organizations must consider before implementing digital health strategies to engage populations.


Delaying Disease Progression Across a Population

Using a clinical stratification methodology to drive personalized health management interventions

This white paper (the second in the series) demonstrates how to use Care Pathways to develop more effective and personalized clinical interventions, and improve long-term health management.

The white paper discusses:

  1. What is Care Pathways and how does this approach differ from traditional risk models
  2. How to use the risk stages of Care Pathways to personalize patient outreach and goal-setting
  3. An introduction to pathway-based outcomes measurement

A Randomized Trial of a Telephone Chronic Care Management Strategy

A study published September 23, 2010 in the New England Journal of Medicine shows how Health Dialog’s enhanced care management programs deliver significant cost savings ($7.96 PMPM) and reduced hospital admissions (over 10%). This peer-reviewed, randomized controlled trial followed 174,120 individuals over 12 months, making it the largest published study of its kind. The cost of this intervention program was less than $2.00 per member per month, resulting in net savings of $6.00 per member per month.


Care Pathways: A Clinical Approach to Population Stratification Analytics

Dispelling the Myths of Traditional Risk Segmentation Models Used in Population Health Management Programs

This white paper will introduce a new methodology for identifying and stratifying individuals for population health management programs. Unlike the traditional risk segmentation approach—which places individuals into a low, moderate, or high risk category—the Care Pathways framework digs deeper to segment the population into 9 clinical-relevant stages of a chronic condition. This approach can support a longer-term population health management strategy and help drive more targeted and personalized patient engagement efforts.

For the purposes of this white paper, we compare the Care Pathways approach to the low-moderate-high risk segmentation approach, and discuss how Care Pathways points to potentially missed clinical and financial opportunities.  


  • Marc Agger, Clinical Informaticist and Senior Scientist, Health Dialog
  • Andrea Fong, VP of Analytics, Health Dialog
  • Yashan Zhong, Research Analyst

Readmissions Diagnostic Whitepaper

Patient readmissions within 30 days of hospital discharge are a major driver of healthcare costs in Medicare and other populations with high levels of hospitalization needs. Learn how Health Dialog can help address this costly problem of hospital readmissions.


From Theory to Practice: Implementing Shared Decision Making at the Point of Care

Learn how to successfully implement shared decision making tools and support directly into provider practices. Dr. Peter Goldbach discusses best practices for helping patients to become active participants in their healthcare decision making. Additionally, Goldbach emphasizes the effectiveness of decision aids and resources for patients as well as consistent dialog between doctor and patient.